Acknowledgement
This work was supported by the National Research Foundation of Korea (NRF) grants funded by the Korean government (MSIP) (2018M3A9D3079290, 2020R1A2C2013258, and 2022M3A9B6017424 to H.-P. Kim).
References
- Vivier E, Tomasello E, Baratin M, Walzer T and Ugolini S (2008) Functions of natural killer cells. Nat Immunol 9, 503-510 https://doi.org/10.1038/ni1582
- Caligiuri MA (2008) Human natural killer cells. Blood 112, 461-469 https://doi.org/10.1182/blood-2007-09-077438
- Kee BL, Morman RE and Sun M (2020) Transcriptional regulation of natural killer cell development and maturation. Adv Immunol 146, 1-28 https://doi.org/10.1016/bs.ai.2020.01.001
- Moretta A, Marcenaro E, Parolini S, Ferlazzo G and Moretta L (2008) NK cells at the interface between innate and adaptive immunity. Cell Death Differ 15, 226-233 https://doi.org/10.1038/sj.cdd.4402170
- Paul S and Lal G (2017) The molecular mechanism of natural killer cells function and its importance in cancer immunotherapy. Front Immunol 8, 1124
- Chen Y, Lu D, Churov A and Fu R (2020) Research Progress on NK cell receptors and their signaling pathways. Mediators Inflamm 2020, 6437057
- Meza Guzman LG, Keating N and Nicholson SE (2020) Natural killer cells: tumor surveillance and signaling. Cancers (Basel) 12, 952
- Wang D and Malarkannan S (2020) Transcriptional regulation of natural killer cell development and functions. Cancers (Basel) 12, 1591
- Bi J and Wang X (2020) Molecular regulation of NK cell maturation. Front Immunol 11, 1945
- Spitz F and Furlong EE (2012) Transcription factors: from enhancer binding to developmental control. Nat Rev Genet 13, 613-626 https://doi.org/10.1038/nrg3207
- Levine M and Tjian R (2003) Transcription regulation and animal diversity. Nature 424, 147-151 https://doi.org/10.1038/nature01763
- Holliday R (2006) Epigenetics: a historical overview. Epigenetics 1, 76-80 https://doi.org/10.4161/epi.1.2.2762
- Mumbach MR, Satpathy AT, Boyle EA et al (2017) Enhancer connectome in primary human cells identifies target genes of disease-associated DNA elements. Nat Genet 49, 1602-1612 https://doi.org/10.1038/ng.3963
- Santosa EK, Lau CM, Sahin M, Leslie CS and Sun JC (2023) 3D chromatin dynamics during innate and adaptive immune memory acquisition. bioRxiv
- Grunstein M (1997) Histone acetylation in chromatin structure and transcription. Nature 389, 349-352 https://doi.org/10.1038/38664
- Gujral P, Mahajan V, Lissaman AC and Ponnampalam AP (2020) Histone acetylation and the role of histone deacetylases in normal cyclic endometrium. Reprod Biol Endocrinol 18, 84
- Bondarev AD, Attwood MM, Jonsson J, Chubarev VN, Tarasov VV and Schioth HB (2021) Recent developments of HDAC inhibitors: emerging indications and novel molecules. Br J Clin Pharmacol 87, 4577-4597 https://doi.org/10.1111/bcp.14889
- Siegel D, Hussein M, Belani C et al (2009) Vorinostat in solid and hematologic malignancies. J Hematol Oncol 2, 31
- Berghuis D, Schilham MW, Vos HI et al (2012) Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysis. Clin Sarcoma Res 2, 8
- Desimio MG, Giuliani E and Doria M (2017) The histone deacetylase inhibitor SAHA simultaneously reactivates HIV-1 from latency and up-regulates NKG2D ligands sensitizing for natural killer cell cytotoxicity. Virology 510, 9-21 https://doi.org/10.1016/j.virol.2017.06.033
- Ogbomo H, Michaelis M, Kreuter J, Doerr HW and Cinatl J Jr (2007) Histone deacetylase inhibitors suppress natural killer cell cytolytic activity. FEBS Lett 581, 1317-1322 https://doi.org/10.1016/j.febslet.2007.02.045
- Pace M, Williams J, Kurioka A et al (2016) Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function. PLoS Pathog 12, e1005782
- Kotzur R, Duev-Cohen A, Kol I, Reches A, Mandelboim O and Stein N (2022) NK-92 cells retain vitality and functionality when grown in standard cell culture conditions. PLoS One 17, e0264897
- Misteli T (2020) The self-organizing genome: principles of genome architecture and function. Cell 183, 28-45 https://doi.org/10.1016/j.cell.2020.09.014
- Fortin JP and Hansen KD (2015) Reconstructing A/B compartments as revealed by Hi-C using long-range correlations in epigenetic data. Genome Biol 16, 180
- Dixon JR, Selvaraj S, Yue F et al (2012) Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 485, 376-380 https://doi.org/10.1038/nature11082
- Rao SS, Huntley MH, Durand NC et al (2014) A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell 159, 1665-1680 https://doi.org/10.1016/j.cell.2014.11.021
- Boto P, Csuth TI and Szatmari I (2018) RUNX3-mediated immune cell development and maturation. Crit Rev Immunol 38, 63-78 https://doi.org/10.1615/CritRevImmunol.2018025488
- North TE, Stacy T, Matheny CJ, Speck NA and de Bruijn MF (2004) Runx1 is expressed in adult mouse hematopoietic stem cells and differentiating myeloid and lymphoid cells, but not in maturing erythroid cells. Stem Cells 22, 158-168 https://doi.org/10.1634/stemcells.22-2-158
- Lai CB and Mager DL (2012) Role of runt-related transcription factor 3 (RUNX3) in transcription regulation of natural cytotoxicity receptor 1 (NCR1/NKp46), an activating natural killer (NK) cell receptor. J Biol Chem 287, 7324-7334 https://doi.org/10.1074/jbc.M111.306936
- Kawane T, Qin X, Jiang Q et al (2018) RUNX2 is required for the proliferation of osteoblast progenitors and induces proliferation by regulating Fgfr2 and Fgfr3. Sci Rep 8, 13551
- Jin YH, Jeon EJ, Li QL et al (2004) Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation. J Biol Chem 279, 29409-29417 https://doi.org/10.1074/jbc.M313120200
- Chuang LS, Ito K and Ito Y (2013) RUNX family: regulation and diversification of roles through interacting proteins. Int J Cancer 132, 1260-1271 https://doi.org/10.1002/ijc.27964
- Lee JW, Kim DM, Jang JW et al (2019) RUNX3 regulates cell cycle-dependent chromatin dynamics by functioning as a pioneer factor of the restriction-point. Nat Commun 10, 1897
- Lotem J, Levanon D, Negreanu V, Leshkowitz D, Friedlander G and Groner Y (2013) RUNX3-mediated transcriptional program in cytotoxic lymphocytes. PLoS One 8, e80467
- Sciume G, Mikami Y, Jankovic D et al (2020) Rapid enhancer remodeling and transcription factor repurposing enable high magnitude gene induction upon acute activation of NK cells. Immunity 53, 745-758 e744
- Zhao X, Peng T, Cao X et al (2022) In vivo G-CSF treatment activates the GR-SOCS1 axis to suppress IFN-gamma secretion by natural killer cells. Cell Rep 40, 111342
- Mevel R, Draper JE, Lie ALM, Kouskoff V and Lacaud G (2019) RUNX transcription factors: orchestrators of development. Development 146, dev148296
- Brillantes M and Beaulieu AM (2019) Transcriptional control of natural killer cell differentiation. Immunology 156, 111-119 https://doi.org/10.1111/imm.13017
- Vogel C and Marcotte EM (2012) Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet 13, 227-232 https://doi.org/10.1038/nrg3185